The objective of this study is to explore and validate a novel prognostic index for patients with locally advanced or metastatic biliary tract cancer (BTC) treated with first‐line therapy with cisplatin, gemcitabine, and durvalumab.
M. Persano, A. Casadei-Gardini, L. Fornaro et al.· Cancer· 0 citations
Personalized medicine has redefined oncology by tailoring treatments to molecular and clinical characteristics. However, despite remarkable advances in biomarker discovery and targeted therapy, the integration of pharmacological principles into precision oncology remains limited. The resulting discrepancy between biolo...
V. Debien, A. Géraud-Crémieux, M. Le Grand et al.· ESMO Open· 0 citations
In surgically managed PDAC patients, young age and normal CA19-9 value carried independent favorable prognostic information, and prognosis was also shaped by nodal status, T stage, and receipt of adjuvant therapy.
I. Garajová, Bing-Zhi Wang, I. Chen et al.· Life· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.